What was Braskem's 2Q26 consolidated recurring EBITDA, and what was the main driver behind this result?

Braskem's 2Q26 consolidated recurring EBITDA was US$1,043 million, primarily driven by stronger international chemical and resin spreads resulting from Middle East-related trade disruptions.

How does Braskem characterize the broader petrochemical market environment despite its strong 2Q26 performance?

Braskem views the petrochemical cycle as structurally challenging due to global overcapacity and moderate demand, and considers the 2Q26 results a tactical opportunity rather than a long-term structural shift.

Braskem (BAK) lifts 2Q26 recurring EBITDA to US$1,043M on stronger spreads

Aug 14, 2026

Braskem reported a 2Q26 recurring EBITDA of US$1,043 million driven by stronger international chemical spreads amid Middle East trade disruptions. Despite structural petrochemical challenges, the company highlighted progress on the Alagoas geological event and strategic priorities for H2 2026.

Stock Titan

2026-04-02

Braskem (NYSE: BAK) weighs creditor protection options while reviewing capital structure

2026-04-04

Pomerantz Law Firm Investigates Braskem S.A. Over Investor Claims

2026-04-08

Braskem Reviews Creditor Options as Shareholders Weigh São Paulo Move

2026-04-08

Braskem Clarifies Capital Structure Review and Plans Shareholder Vote on Legal Domicile Change

2026-04-09

Braskem (BAK) Outlines Braskem Idesa Missed Interest Payments and Debt Talks